XanGo

XANGO, LLC.

Type	Private
Industry	Multi-level Marketing
Founded	2002
Headquarters	Lehi, Utah, USA
Key people	Aaron Garrity, Gary Hollister, Joe Morton, Gordon Morton, Bryan Davis and Kent Wood
Website	XANGO.com

XANGO, LLC, founded in 2002, is a privately owned international multilevel marketing company based in Lehi, Utah. The company markets and distributes XANGO Juice, a blended juice product consisting of mangosteen and other juices, and skin care, personal care, energy supplement and nutritional supplement products formulated with botanical ingredients.

Company overview

Executives

• Gary Hollister, Founder, Chairman Emeritus, former Chief Executive, former Chairman of the Board
• Aaron Garrity, Founder, Chairman of the Board, CEO, former President
• Joe Morton, Founder, Board of Directors
• Gordon Morton, Founder, Board of Directors
• Kent Wood, Founder, Board of Directors
• Bryan Davis, Founder, Board of Directors

Revenue

XANGO is a privately held company and as such does not publicly disclose its financial statements. Company press releases in 2005-2006 stated that sales totalled $40 million in 2003 and $150 million in 2004, and that 2005 sales were more than twice those of 2004. In October 2007 the company said that cumulative sales since its inception five years earlier were over $1 billion and by November 2008 had exceeded $1.5 billion.

In December 2012, it was reported that XANGO concluded its first ten years of operation in November 2012 with sales operations in 43 countries, 27 office locations, 49 distribution centers, more than two million distributors, and about $2 billion in cumulative revenues. "Their goal for the future is impressive: to double their business in North America by the end of 2013," according to Direct Selling News

Financial sponsorships and contributions

In November 2006, XANGO, LLC, became the official corporate jersey-front sponsor of Real Salt Lake, a MLS soccer team based in Salt Lake City, Utah, for four years, at a cost of between $500,000 and $1 million per year. In 2006, the company made a 5-year, $1 million grant to an Orem, Utah arts council for naming rights to what is now called the "XANGO Grand Theater". XANGO, LLC, has been the top contributor to the political campaign of Utah Senator Orrin Hatch, contributing $47,200 in 2008 and $46,700 in 2006, according to the Center for Responsive Politics.

From its founding, XanGo has dedicated a percentage of net corporate profits to children's charities. The XanGo Goodness Foundation is a 501(3)(c) charitable foundation. One of the children's charities supported is Operation Kids. In August 2011, Americares reported that XanGo had started shipping its Meal Pack products to Kenya for famine relief. As of December 2012, it was reported that XANGO has provided about 5 million supplemental meals to malnourished persons via its Americares partnership. Through Operation Smile, XANGO has provided 1,700 surgeries for children born with facial deformities.

Product overview

Products and distribution

XANGO (say "ZAYN-go") is the common name of the company, XanGo LLC, as well as its first and flagship juice product XANGO (also often called XANGO Juice). While XANGO's business model is direct sales via multi-level marketing rather than retail sales, its products represent the wellness industry.

XANGO Juice is sold in the U.S. and (as of late-2011) exported to Australia, Canada, Germany, Japan, Malaysia, Mexico, Singapore, Sweden, and the United Kingdom. The company began operating in Taiwan as of October 2007.

The company sells XANGO Juice mainly using a nine-level multi-level marketing structure. In June 2006, the company said it had 350,000 distributors. In July, the company told the Federal Trade Commission that there were "roughly 500,000 distributors worldwide", and in November, it reported having more than 600 employees at its Lehi headquarters and more than 500,000 independent distributors in 15 international markets. In July 2007, it said it had about 700,000 distributors, of whom an estimated 70 percent simply use their status to buy the juice at the discounted membership price. In October 2008, it said that it operated in 24 countries and had more than 1 million independent distributors. In 2013, the company states that it now operates in 43 countries.

In the United States, XANGO Juice sells for a retail price of $37.50 for a 750 ml (25.35 ounce) bottle. Purchasing through XANGO's distributor group, Juice and other products can be bought at wholesale prices. XANGO also sells Reserve, a more expensive version of its original juice product with a higher mangosteen content.

In 2009, XANGO launched Glimpse Skin Care, products made using undefined quantities of mangosteen that may support skin health. The Campaign for Safe Cosmetics recognized XANGO as a "Champion of Safe Cosmetics" in 2011. XANGO has added other products to its Glimpse family, including their Luminescence Collection, Mineral Treatment, and Mangosteen Oils. They supply personal care products via their Juni family in shampoos, conditioners, skin lotion, bar and body soaps.

XANGO also sells other products marketed in the wellness category. Its 3SIXTY5 and 3SIXTY5 for Kids are products manufactured to contain multiple vitamins. Its Precis line includes Men's Health, Omega-3, and Rest & Renew. Its Favao products promoted for weight control include body cleanse, fiber, and various protein supplements, all which the company claims to include mangosteen components.^{[citation needed]} XANGO sells Eleviv capsules which contain four herbal ingredients.

XANGO Juice composition

XANGO Juice is a blend of mangosteen aril and pericarp purée with juice concentrates of eight other fruits: apple, pear (juice and purée), grape, blueberry, raspberry, strawberry, cranberry and cherry. Other ingredients include citric acid, natural flavor, pectin, xanthan gum, sodium benzoate, and potassium sorbate. XANGO claims its juice contains xanthonoid compounds from the mangosteen pericarp.

In September 2006, ConsumerLab confirmed that XANGO Juice does not contain any World Anti-Doping Agency (WADA) banned substances. ConsumerLab said that XANGO Juice is a "zero-tolerance level product" and has no detectable diuretics, masking agents, beta blockers or related banned substances.

The Associated Press commissioned the Linus Pauling Institute to measure the in vitro antioxidant strength of XANGO Juice against retail fruit juices. The antioxidant strength of XanGo Juice measured slightly higher than cranberry juice but lower than black cherry and less than half the value for blueberry juice. However, the value of in vitro analysis of antioxidant strength is in question, as there is no current evidence that antioxidant phytochemicals present in XANGO or other fruit juices actually have functions inside the human body. The measurements of antioxidant strength apply to test tubes, but consumed juices are affected by stomach acids that would neutralize or destroy antioxidant value preventing the same biological effects in vivo.

In 2002, XANGO founders Aaron R. Garrity, Gordon A. Morton, and Joseph C. Morton (doing business as DBC, LLC) applied for a United States patent (#6730333) for XANGO Juice; however the application was rejected by the United States Patent and Trademark Office on April 21, 2005. On November 3, 2008, the U.S. Court of Appeals for the Federal Circuit ruled that the decision of a patent appeals board to deny XANGO's patent application would still stand.

Controversy

Pericarp xanthones and potential health effects

The company's distributors had illegally used marketing materials to promote mangosteen juice claiming more than 20 human health benefits, including "anti-inflammatory," "anti-microbial," "anti-fungal," "anti-viral," "anti-cancer," "anti-ulcer," "anti-hepatotoxic," "anti-rhinoviral," and "anti-allergic" effects. Promotional literature for the product cites antioxidants from the inedible pericarp of the fruit as providing health benefits. None of these claims, however, has scientific proof established by peer-reviewed research and human clinical trials, as discussed below.

The American Cancer Society profile of mangosteen juice states there is no reliable evidence that mangosteen juice, purée, or bark is effective as a treatment for cancer in humans. As of April 2013, it also states that the mangosteen "fruit has been shown to be rich in anti-oxidants. Very early laboratory studies suggest it may have promise as a topical treatment for acne. Early small laboratory and animal studies suggest that further research should be done to determine whether it can help to prevent cancer in humans."

Pericarp xanthones remain under preliminary research to define their potential properties, which may include antioxidant and chemopreventive effects. In 2007, the Mayo Clinic stated there was laboratory evidence that mangosteen xanthones had anti-inflammatory activity, but there was no evidence demonstrating such anti-inflammatory effects in humans. Since then, Mayo Clinic has updated its comments to say "A number of laboratory and animal studies suggest that mangosteen has significant anti-inflammatory effects. And a few small-scale studies in humans indicate that the juice helps reduce blood levels of C-reactive protein (CRP)."

In 2009, XanGo scientific adviser, David Morton, participated in a four-part debate on the asserted claims of mangosteen health benefits.

U.S. FDA warning

On September 20, 2006, the United States Food and Drug Administration issued a Warning Letter to XANGO LLC International in response to the company's promotion of XANGO Juice as an aid to treat and/or cure various diseases. The agency's letter warned that XANGO Juice had not been properly tested for safety and efficacy, and as a proposed new drug, it could not be legally sold in the U.S. without prior approval of the FDA. XANGO was warned that it could face enforcement action including seizure and/or injunction of products or suspension of business. Under FDA drug labeling rules, XANGO, as manufacturer, is responsible for satisfying scientific criteria to make health claims on its product labels and all marketing materials. As of September 2008, the case remained open.

Critical assessments of XANGO Juice

The Mayo Clinic said in October 2005 that "there are no published clinical trials showing evidence that either the fruit or its juice — marketed under the name XANGO Juice — is an effective treatment for arthritis, cancer or any other disorder in humans." Since that time, Mayo Clinic has updated its reference. As of April 2013, it says "A number of laboratory and animal studies suggest that mangosteen has significant anti-inflammatory effects. And a few small-scale studies in humans indicate that the juice helps reduce blood levels of C-reactive protein (CRP)."

In February 2006, the U.C. Berkeley Wellness Newsletter, sponsored by the University of California at Berkeley, said that "Mangosteen marketers make farfetched and unsubstantiated claims for their products." The newsletter notes that "there are no clinical trials, and what happens in a test tube or animal may not occur in a human. Any reported benefits in humans have been anecdotal. No one even knows if the processed fruit juice and capsules retain the potentially beneficial compounds. What’s more, the juice is typically a mix of fruit juices — with an undisclosed amount of mangosteen in it."

Dr. Ralph Moss, author of several books and newsletters on cancer research, has said of mangosteen juice:

In my opinion, what we have here is simply an overpriced fruit drink. Fruit drinks are often healthful beverages. But the only reason I can see that the promoters of mangosteen can get away with charging $37 for this product is that they are playing on patients' hopes and fears in a cynical way. Without the health claims, open or implied, the product could only be sold for at most $5 or $6 (which, for example, is the cost of antioxidant-rich pomegranate juice).

A 2008 medical case report described a patient with severe acidosis possibly attributable to a year of daily use (to lose weight, dose not described) of mangosteen juice (brand not described) infused with xanthonoids, as occurs in the manufacture of XanGo juice. The authors proposed that chronic exposure to alpha-mangostin, a xanthone, could be toxic to mitochondrial function, leading to impairment of cellular respiration and production of lactic acidosis.

Litigation

Tahitian Noni International (TNI), a rival MLM beverage company, sued XANGO, LLC, and several of its top executives in February 2003 in the 4th District Court in Provo, Utah, alleging that XANGO executives stole TNI's concept for a mangosteen-based supplement while they were employed by TNI's parent-company. After a countersuit against TNI was launched by XANGO, LLC, the two parties settled out of court. A joint statement by TNI and XANGO said that they had "agreed to resolve their disputes and the litigation between them and their founders" but the particulars of the settlement were not disclosed.

In 2009 The State of Utah's Supreme Court gave the green light to a XanGo investor to proceed with a suit that alleges corporate looting and mismanagement of millions of dollars by the Lehi supplements company's founders for their personal expenses including luxury cars and performance-enhancing medical treatments. In a 5-0 decision issued the Utah Supreme Court overturned a 4th District Court ruling that dismissed a lawsuit filed in 2007 by Angel Investors LLC alleging XanGo's founders took millions of dollars in personal loans from the company and paid themselves excessive salaries while wasting corporate assets. In 2010 XanGo settled with Angel Investors for an undisclosed amount of money. "Angel Investors, who had owned no more than 1 percent of the Lehi company, had charged in three lawsuits in Utah County that the founders deprived them of some of the return on their investment. The group cited such expenditures as $6,000 monthly auto allowances, family vacations and, in one case, $20,000 worth of home furnishings." The terms of the settlement were not disclosed.

In 2012 XanGo had issues concerning taxes. "At the top of 2012 tax delinquency lists was $347,816 owed for the Lehi headquarters of Xango, a multilevel marketing company that sells nutritional supplements — which has its name on the uniforms of Real Salt Lake soccer players. That property is owned by Thai Properties, which is part of the same corporate group as Xango, said Nate Brown, chief financial officer for Xango".